Top Markets
Coin of the day
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Rank in Stocks #12975
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Share Price
$0.66137861
Market Cap
$531.70M
Change (1 day)
-2.45%
Change (1 year)
-42.12%
Country
CN
Trade Ocumension Therapeutics (1477)

Category

Stock price history for Ocumension Therapeutics (1477)
Highest end of day price: $0.68 on 2026-08-01

Lowest end of day price: $4.11 on 2020-07-01
Stock price history of Ocumension Therapeutics from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -10.84%
2025 66.97%
2024 -28.81%
2023 -25.43%
2022 -45.72%
2021 -33.26%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$752.76 6.28%
CH